Vancouver, British Columbia–(Newsfile Corp. – September 5, 2025) – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced that the Company will be participating in the H.C. …
Read More »
Breaking News
- Trican Well Service Ltd. Announces Fourth Quarter 2025 Conference Call
- Metalsource Mining Closes Private Placement
- BTCC Exchange Concludes 2025 with 11 Million Users, $53.1 Billion in Tokenized RWA Futures, and Industry Recognition as Best CEX
- Hong Kong Tech Exhibits Immense Potential at CES 2026 with 61 Tech Companies Ready for Global Markets
- Advocate of Al Qaeda linked terrorist appointed as New York Chief Legal Advisor by Zohran Mamdani
- US lawmakers vouches bail for Umar Khalid; An attempt to destabilise regime & breach judicial sovereignty in India?
- Bangladesh: Family of Hindu man burnt by Islamists demand justice, say motive of attack unclear
- Karnataka: NIA files chargesheet against 3 more accused for aiding LeT terrorist Tehseen Nasir inside prison
- Assam: NIA court sentences Hizb-ul-Mujahideen terrorist Md. Kamruz for life; 5 Islamists convicted for terror plot
- Bold Ventures Closes $776,800 Non-Brokered Private Placement
Matribhumi Samachar
Address : 125 - Rajiv Nagar, Vinayakpur, Kanpur - 208025
Mo. No.: 8303063085
Email: [email protected]
Managed By Y2KSOLUTION
Copyright © Matribhumi Samachar